Clarametyx Biosciences Announces Completion of Enrollment in Phase 2a Study of CMTX-101 in Cystic Fibrosis

CLARAMETYX BIOSCIENCES ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE 2A STUDY OF…

October 16, 2025